ACEi angiotensin converting enzyme inhibitor
ADA American Diabetes Association
ACR urine albumin to creatinine ratio
ADR adverse drug reactions
ARB angiotensin receptor blocker
ASCVD atherosclerotic cardiovascular disease e.g., angina, myocardial infarction, stroke
BMI body mass index
BNF British National Formulary
CFS Clinical Frailty Scale
CKD chronic kidney disease
CrCl creatinine clearance
CVD cardiovascular disease
DKA diabetic ketoacidosis
DPP-4i dipeptidyl peptidase-4 inhibitor e.g., alogliptin, linagliptin, sitagliptin, saxagliptin, vildagliptin
DSMES diabetes self-management education and support
EASD European Association for the Study of Diabetes
eDKA

euglycaemic diabetic ketoacidosis

eGFR estimated glomerular filtration rate
FGM flash glucose monitor
GLP-1RA glucagon-like peptide 1 receptor agonist e.g., dulaglutide, exenatide, liraglutide, lixisenatide, and semaglutide
HbA1c glycated haemoglobin
(c)HF (chronic) heart failure
LVH left ventricular hypertrophy
MACE major adverse cardiovascular events
MDD major depressive disorder
MHRA Medicines and Healthcare products Regulatory Agency
NICE National Institute for Health and Clinical Excellence
SG Scottish Government
SGLT-2i sodium-glucose co-transporter-2 inhibitor e.g., canagliflozin, dapagliflozin, empagliflozin
SIMD Scottish Index of Multiple Deprivation
SMG self-monitoring glucose
SU sulfonylurea
TZD thiazolidinediones e.g., pioglitazone